X4 Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 3/6
X4 Pharmaceuticals has a total shareholder equity of $94.5M and total debt of $75.0M, which brings its debt-to-equity ratio to 79.4%. Its total assets and total liabilities are $210.6M and $116.2M respectively.
Key information
79.4%
Debt to equity ratio
US$75.03m
Debt
| Interest coverage ratio | n/a |
| Cash | US$168.75m |
| Equity | US$94.45m |
| Total liabilities | US$116.16m |
| Total assets | US$210.61m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 48Q's short term assets ($175.4M) exceed its short term liabilities ($28.9M).
Long Term Liabilities: 48Q's short term assets ($175.4M) exceed its long term liabilities ($87.3M).
Debt to Equity History and Analysis
Debt Level: 48Q has more cash than its total debt.
Reducing Debt: 48Q's debt to equity ratio has increased from 26.9% to 79.4% over the past 5 years.
Debt Coverage: 48Q's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 48Q's interest payments on its debt are well covered by EBIT.